Your Article Summary
See Latest ArticlesFactors Related to the Use of Dietary Supplements by Cancer Survivors
Journal of Alternative and Complementary Medicine, 06/04/09
Ferrucci LM et al. - Estimates of the use of complementary and alternative medicine (CAM) among cancer survivors vary widely. Dietary supplements are an important CAM therapy to examine because of their potential to interact with conventional cancer therapies. The authors estimated the prevalence of dietary supplement use in a population-based sample of cancer survivors of the 10 most common cancers and examined potential correlates of use...Use of dietary supplements after cancer diagnosis was quite common among this population-based sample of cancer survivors. Although gender and education were associated with use, it is important that clinicians discuss supplement use with all cancer survivors.
Related Articles
Muscle atrophy in cachexia: can dietary protein tip the balance?
Current Opinion in Clinical Nutrition & Metabolic Care, 10/26/09
Relevance Score: 68%
Dietary supplementation by older adults in southern China: a hospital outpatient clinic study
BMC Complementary and Alternative Medicine, 10/21/09
Relevance Score: 68%
Dietary Supplements May Increase Longevity Of HIV Patients
Internet Source, 11/09/09
Relevance Score: 67%
Effect of a dietary intervention and n-3 fatty acid supplementation on measures of serum lipid and insulin sensitivity in persons with HIV
American Journal of Clinical Nutrition, 10/28/09
Relevance Score: 67%
Reproducibility of reported nutrient intake and supplement use during a past pregnancy: a report from the Children's Oncology Group
Paediatric and Perinatal Epidemiology, 10/20/09
Relevance Score: 67%
Today in Alternative Therapies...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy of Goshajinkigan for Peripheral Neurotoxicity of Oxaliplatin in Patients with Advanced or Recurrent Colorectal Cancer
Evidence-based Complementary and Alternative Medicine , 12/02/09
Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3
Carcinogenesis, 12/01/09
A phase 2 trial exploring the effects of high-dose (10,000 IU/day) Vitamin D3 in breast cancer patients with bone metastases
Cancer, 11/18/09